Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Elman

Showing results (51-60 of 147) with videos related to

Pageof 15
Sort By:
Journal of Child and Adolescent Psychopharmacology|December 26, 2008
Neuroanatomic comparison of bipolar adolescents with and without cannabis use disordersKelly Jarvis, Melissa P DelBello, Neil Mills, et al.
Plos One|April 18, 2013
Neurological soft signs in individuals with pathological gamblingIgor Elman, Tamara V Gurvits, Evelyne Tschibelu, et al.
CNS Spectrums|July 26, 2021
Migraine: interactions between brain's trait and stateEdina Szabo, Stephen Green, Keerthana Deepti Karunakaran, et al.
Journal of Addiction Medicine|July 29, 2016
Co-occurring Disordered Gambling Among Treatment-Seekers at a Community Outpatient Addiction ClinicIgor Elman, Jacob Borodovsky, Margaret Howard, et al.
Addiction Biology|December 17, 2013
Emotional graphic cigarette warning labels reduce the electrophysiological brain response to smoking cuesAn-Li Wang, Dan Romer, Igor Elman, et al.
The European Journal of Neuroscience|May 11, 2022
The solitary nucleus connectivity to key autonomic regions in humansJulia Forstenpointner, Anne Margarette S Maallo, Igor Elman, et al.
Frontiers in Bioscience (Scholar Edition)|January 3, 2018
Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti- reward systemsMark S Gold, Kenneth Blum, Marcelo Febo, et al.
Frontiers in Psychiatry|August 21, 2023
Association between body mass index and treatment completion in extended-release naltrexone-treated patients with opioid dependenceXinyi Li, Daniel D Langleben, Kevin G Lynch, et al.
Psychopharmacology|June 5, 2004
Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophreniaIgor Elman, David Rott, Alan I Green, et al.
Journal of General Internal Medicine|May 18, 2026
GLP-1 Receptor Agonist Treatment and Health Outcomes in Methadone-Treated Patients with Opioid Use Disorder and DiabetesJane Y Pan, Igor Elman, Krisha Panchal, et al.
Pageof 15

Showing results (51-60 of 147) with videos related to

Sort By:
Pageof 15
Journal of Child and Adolescent Psychopharmacology|December 26, 2008
Neuroanatomic comparison of bipolar adolescents with and without cannabis use disordersKelly Jarvis, Melissa P DelBello, Neil Mills, et al.
Plos One|April 18, 2013
Neurological soft signs in individuals with pathological gamblingIgor Elman, Tamara V Gurvits, Evelyne Tschibelu, et al.
CNS Spectrums|July 26, 2021
Migraine: interactions between brain's trait and stateEdina Szabo, Stephen Green, Keerthana Deepti Karunakaran, et al.
Journal of Addiction Medicine|July 29, 2016
Co-occurring Disordered Gambling Among Treatment-Seekers at a Community Outpatient Addiction ClinicIgor Elman, Jacob Borodovsky, Margaret Howard, et al.
Addiction Biology|December 17, 2013
Emotional graphic cigarette warning labels reduce the electrophysiological brain response to smoking cuesAn-Li Wang, Dan Romer, Igor Elman, et al.
The European Journal of Neuroscience|May 11, 2022
The solitary nucleus connectivity to key autonomic regions in humansJulia Forstenpointner, Anne Margarette S Maallo, Igor Elman, et al.
Frontiers in Bioscience (Scholar Edition)|January 3, 2018
Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti- reward systemsMark S Gold, Kenneth Blum, Marcelo Febo, et al.
Frontiers in Psychiatry|August 21, 2023
Association between body mass index and treatment completion in extended-release naltrexone-treated patients with opioid dependenceXinyi Li, Daniel D Langleben, Kevin G Lynch, et al.
Psychopharmacology|June 5, 2004
Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophreniaIgor Elman, David Rott, Alan I Green, et al.
Journal of General Internal Medicine|May 18, 2026
GLP-1 Receptor Agonist Treatment and Health Outcomes in Methadone-Treated Patients with Opioid Use Disorder and DiabetesJane Y Pan, Igor Elman, Krisha Panchal, et al.
Pageof 15